Fintel reports that on November 10, 2025, B of A Securities maintained coverage of Moderna (NasdaqGS:MRNA) with a ...

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...

That something as simple as a COVID-19 vaccine might improve survival in cancer patients receiving standard immunotherapy has ...

Q3 earnings beat estimates but pipeline setback and lower 2025 guidance raise concerns. Full analysis of results and outlook.

Researchers discovered that embryos must clear maternal mRNAs to develop properly. When cleanup fails, it causes aberrant ...

RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the ...

New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.

All of these questions deserve urgent exploration. Unfortunately, the discovery comes at a particularly difficult moment for ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...